Data

Lu Rahman spoke to Ashley Zehnder, CEO of Fauna Bio, a biotech harnessing the power of comparative and functional animal genomics to find better therapies for human disease, including neurologic, metabolic, fibrotic and cardiovascular disorders. “Comparative genomics is the process of using data from mammals and other species to show us where the most important […]

Life sciences company PerkinElmer is exhibiting at the Bio-IT World Conference and Expo this week ( 3-5 May) in Boston US.   The company is exhibiting a range of solutions that can help researchers in labs make well-informed, data-driven decision on therapeutic candidates by using cloud-based informatics solutions and strategic IT services.  The company is showcasing […]

The European Medicines Agency (EMA) has confirmed that the UNICOM’s DADI (Digital Application Dataset Integration) project will now serve as a ‘Plan B’ for the implementation of regulatory data submissions. Amplexor’s Renato Rjavec looks at the opportunities and challenges this presents for pharma companies. A more data-driven way of managing regulated product data, based on […]

New global data analysis from Phesi shows the extent of the impact from the war in Ukraine on clinical development.   Phesi analysed pivotal trials sponsored by pharmaceutical companies that represent the most critical global clinical development activities.   The findings  The findings show that as of March 16, 2022, there were 65,593 recruiting investigator sites globally […]

New results from an observational data analysis of asthma inhaler therapy found that short-acting beta2-agonist (SABA) reliever overuse is a global issue adversely impacting asthma outcomes.1,2   Data from across the SABA Use IN Asthma (SABINA) global programme have been published in The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice) and the […]

More than half of all scientific research is irreproducible, and more than 80% of scientific research data is being lost within 20 years. In the biomedical field alone, irreproducible research costs the industry £28 billion (US$38 billion) every year. Megan Thomas talks to Founder of Labstep Jake Schofield, about this issue.  MT: Huge amounts of scientific data […]

Pharmaceutical companies must keep improving Covid-19 treatments in line with new variants without sidelining work in other areas of health, according to new data from YouGov and Informa Pharma Intelligence, a provider for the biopharma industry.   The report  This data, included in Informa Pharma’s ‘Q4 2021 Clinical Trials and the Covid 19 Landscape’ report, is […]

The US Food and Drug Administration (FDA) has approved a long-acting HIV prevention medication for the first time.   The drug  Developed by ViiV Healthcare, the medicine is long-acting cabotegravir injected once every two months. The FDA has approved the medicine for use by adults and adolescents weighing at least 35 kilograms who are at risk of sexually […]

Twist Bioscience has launched Revelar Biotherapeutics to develop and commercialise an antibody that neutralises all known variants of concern of the SARS-CoV-2 virus in preclinical studies.   In addition, Revelar will have the ability to leverage the antibody discovery and optimisation platform of Twist Biopharma to license additional antibodies for up to five targets over the next four years.  Emily Leproust, CEO and co-founder of Twist Bioscience, said: […]

The Comprehensive Resistance Prediction for Tuberculosis International Consortium (CRyPTIC) research project has reportedly collected the largest ever global dataset of clinical M. tuberculosis samples from across the world consisting of 15,211 samples from 27 countries on five continents.  Using a new quantitative test for drug resistance and a new approach which identifies all the genetic […]